share_log

PharmaCyte Biotech | 3: Initial statement of beneficial ownership of securities-Director Loehr Matthias

Apr 11, 2022 09:00
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more